Neuphoria Therapeutics Adopts Stockholder Rights Plan

Neuphoria Therapeutics Inc. has adopted a stockholder rights plan, effective immediately, to protect the interests of its stockholders. The plan is designed to prevent any person or group from acquiring beneficial ownership of 15% or more of the company's common stock without the approval of the Board of Directors. The rights will expire on October 27, 2026, unless earlier redeemed or exchanged by the company. The plan was adopted in response to significant and rapid accumulations of the company's common stock by certain investors, including one investor who holds more than 20% of the outstanding common stock. The rights plan aims to provide the Board with sufficient time to make informed decisions in the best interests of the company and its stockholders.